MedImmune Inc. sales and marketing update

MedImmune Inc. (MEDI) MedImmune Inc. (MEDI) reported first quarter sales of $1.6 million, which consisted entirely of sales of its CytoGam targeted immune globulin, whose distribution rights were re...